Qube Research & Technologies (QRT)
EW icon

Qube Research & Technologies (QRT)’s Edwards Lifesciences EW Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.5M Sell
414,438
-380,750
-48% -$31.9M 0.03% 607
2026
Q1 		$63.7M Sell
795,188
-320,036
-29% -$26.4M 0.07% 339
2025
Q4 		$95.1M Buy
1,115,224
+450,478
+68% +$37M 0.1% 261
2025
Q3 		$51.7M Buy
664,746
+313,805
+89% +$24.5M 0.05% 450
2025
Q2 		$27.4M Buy
+350,941
New +$26.2M 0.03% 716
2024
Q4 		– Sell
-626,768
Closed -$43.9M – 3557
2024
Q3 		$41.4M Buy
+626,768
New +$45.5M 0.06% 400
2024
Q2 		– Sell
-4,793
Closed -$458K – 4057
2024
Q1 		$458K Sell
4,793
-210,665
-98% -$17.7M ﹤0.01% 2582
2023
Q4 		$16.4M Sell
215,458
-182,439
-46% -$12.7M 0.03% 571
2023
Q3 		$27.6M Buy
397,897
+374,577
+1,606% +$30.1M 0.07% 329
2023
Q2 		$2.2M Sell
23,320
-157,912
-87% -$13.7M 0.01% 1011
2023
Q1 		$15M Sell
181,232
-118,044
-39% -$9.28M 0.06% 333
2022
Q4 		$22.3M Sell
299,276
-24,782
-8% -$1.91M 0.12% 249
2022
Q3 		$26.8M Buy
+324,058
New +$31.2M 0.16% 168
2021
Q4 		– Sell
-92,525
Closed -$10.5M – 2649
2021
Q3 		$10.5M Buy
92,525
+78,253
+548% +$8.93M 0.13% 190
2021
Q2 		$1.48M Buy
+14,272
New +$1.35M 0.02% 796
2021
Q1 		– Sell
-68,273
Closed -$6.23M – 2045
2020
Q4 		$6.23M Buy
68,273
+43,196
+172% +$3.58M 0.09% 258
2020
Q3 		$2M Sell
25,077
-60,268
-71% -$4.7M 0.03% 637
2020
Q2 		$5.9M Sell
85,345
-73,580
-46% -$5.23M 0.09% 300
2020
Q1 		$9.99M Buy
+158,925
New +$11.5M 0.41% 42
2019
Q3 		– Sell
-35,178
Closed -$2.17M – 307
2019
Q2 		$2.17M Buy
35,178
+8,769
+33% +$530K 0.52% 43
2019
Q1 		$1.68M Buy
26,409
+20,697
+362% +$1.18M 0.22% 115
2018
Q4 		$292K Sell
5,712
-11,598
-67% -$587K 0.13% 200
2018
Q3 		$1M Buy
+17,310
New +$847K 0.13% 120

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Qube Research & Technologies (QRT)'s EW Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Edwards Lifesciences (EW) stake by 48% in Q2 2026, selling an estimated $31.9M and leaving 414,438 shares worth $37.5M. The position accounts for 0.03% of the portfolio, ranked #607.

Qube Research & Technologies (QRT) first reported a position in EW in Q3 2018 and has held it in 23 quarters since. The position peaked at $95.1M in Q4 2025. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Qube Research & Technologies (QRT) held 414,438 shares of Edwards Lifesciences worth $37.5M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 380,750 Edwards Lifesciences shares in Q2 2026, an estimated $31.9M.
  • Edwards Lifesciences made up 0.03% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #607 holding.
  • Qube Research & Technologies (QRT) first reported a position in Edwards Lifesciences in Q3 2018 and has held it in 23 quarters since.
  • Qube Research & Technologies (QRT)'s Edwards Lifesciences position peaked at $95.1M in Q4 2025.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.